Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation

[Image: see text] Docetaxel (DCX) is a second generation taxane. It is approved by the U.S. Food and Drug Administration for the treatment of various types of cancer, including breast, non-small cell lung, and head and neck cancers. However, side effects, including those related to Tween 80, an exci...

Descripción completa

Detalles Bibliográficos
Autores principales: Naguib, Youssef Wahib, Rodriguez, B. Leticia, Li, Xinran, Hursting, Stephen D., Williams, Robert O., Cui, Zhengrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993949/
https://www.ncbi.nlm.nih.gov/pubmed/24621456
http://dx.doi.org/10.1021/mp4006968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993949/
https://www.ncbi.nlm.nih.gov/pubmed/24621456
http://dx.doi.org/10.1021/mp4006968

Ejemplares similares